JP2004515222A - ヒトキニノゲンd5ドメインポリペプチドおよびこれらの使用 - Google Patents
ヒトキニノゲンd5ドメインポリペプチドおよびこれらの使用 Download PDFInfo
- Publication number
- JP2004515222A JP2004515222A JP2002519506A JP2002519506A JP2004515222A JP 2004515222 A JP2004515222 A JP 2004515222A JP 2002519506 A JP2002519506 A JP 2002519506A JP 2002519506 A JP2002519506 A JP 2002519506A JP 2004515222 A JP2004515222 A JP 2004515222A
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cells
- tumor
- cell
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22019400P | 2000-07-24 | 2000-07-24 | |
PCT/US2001/023185 WO2002014369A2 (fr) | 2000-07-24 | 2001-07-24 | Polypeptides du domaine d5 humain de production de kinine s |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004515222A true JP2004515222A (ja) | 2004-05-27 |
JP2004515222A5 JP2004515222A5 (fr) | 2005-12-22 |
Family
ID=22822460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002519506A Withdrawn JP2004515222A (ja) | 2000-07-24 | 2001-07-24 | ヒトキニノゲンd5ドメインポリペプチドおよびこれらの使用 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1305342A2 (fr) |
JP (1) | JP2004515222A (fr) |
AU (1) | AU2001277119A1 (fr) |
WO (1) | WO2002014369A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1357930B1 (fr) | 2001-02-05 | 2005-11-02 | Innoventus Project AB | Histidine-rich glycoprotein (hrgp) pour l'inhbition de l'angiogenese |
AU2012201537B2 (en) * | 2002-07-15 | 2014-06-05 | Board Of Regents, The University Of Texas System | Peptides binding to phosphatidylethanolamine and their use in treating viral infections and cancer |
US7378386B2 (en) | 2002-07-15 | 2008-05-27 | Board Of Regents, The University Of Texas System | Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives |
US6987270B2 (en) | 2003-05-07 | 2006-01-17 | General Electric Company | Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes |
GB0821721D0 (en) * | 2008-11-27 | 2008-12-31 | Hansa Medical Ab | Antimicrobial therapy |
WO2014194259A1 (fr) * | 2013-05-30 | 2014-12-04 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Procédés et compositions pour traiter des maladies cérébrales |
US10696728B2 (en) | 2014-07-03 | 2020-06-30 | Chunlei Liu | Polypeptides, related nucleic acids, and their uses for cell modulation and treatments |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ511488A (en) * | 1998-10-16 | 2003-10-31 | Immunex Corp | Inhibitors of platelet activation and recruitment comprising an Ala residue and heterologous peptides capable of forming a stable secondary structure attached to a CD39 polypeptide |
EP1137659A4 (fr) * | 1998-11-10 | 2005-08-10 | Univ Temple | Inhibition de l'angiogenese par du kininogene de poids moleculaire eleve et analogues peptidiques dudit kininogene |
-
2001
- 2001-07-24 JP JP2002519506A patent/JP2004515222A/ja not_active Withdrawn
- 2001-07-24 WO PCT/US2001/023185 patent/WO2002014369A2/fr active Application Filing
- 2001-07-24 EP EP01954904A patent/EP1305342A2/fr not_active Withdrawn
- 2001-07-24 AU AU2001277119A patent/AU2001277119A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002014369A9 (fr) | 2003-04-03 |
EP1305342A2 (fr) | 2003-05-02 |
WO2002014369A2 (fr) | 2002-02-21 |
WO2002014369A3 (fr) | 2002-09-12 |
AU2001277119A1 (en) | 2002-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7807621B2 (en) | Anti-invasive and anti-angiogenic compositions | |
JP3880593B2 (ja) | アンジオスタチンおよび血管形成の抑制におけるその使用 | |
JP3787157B2 (ja) | アンジオスタチンフラグメント、アンジオスタチン凝集体および使用方法 | |
JP2004519215A (ja) | クローディンポリペプチド | |
JP2000509993A (ja) | アポリポタンパク質b―100由来の抗凝血性ペプチド断片 | |
JPH04503761A (ja) | Pai―2の変異体 | |
KR20010072825A (ko) | 안지오시딘: Cys-Ser-Val-Thr-Cys-Gly서열 특이적인 종양 세포 부착 수용체 | |
JP2004515222A (ja) | ヒトキニノゲンd5ドメインポリペプチドおよびこれらの使用 | |
JP2852192B2 (ja) | uPARのドメイン2+3のuPA結合部位および抗体 | |
US20050124794A1 (en) | Cell surface tropomyosin as a target of angiogenesis inhibition | |
US20140342990A1 (en) | Maspin-based treatment and prevention of cancer | |
JP2006527192A (ja) | 血管内皮増殖因子融合構築物およびその使用方法 | |
US20060153831A1 (en) | Antithrombosis enzyme from the snake venom of Agkistrodon acutus | |
US20030082740A1 (en) | Histidine proline rich glycoprotein (HPRG) as an anti-angiogenic and anti-tumor agent | |
US7119069B2 (en) | Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent | |
WO2002069885A2 (fr) | Compositions anti-invasives et anti-angiogeniques et methodes de traitement de tumeurs cerebrales et d'autres pathologies | |
JP2002535372A (ja) | プラスミノーゲンクリングル4領域フラグメントおよび利用法 | |
AU2002247129A1 (en) | Histidine proline rich glycoprotein (HPRG) as an anti-angiogenic and anti-tumor agent | |
WO2001042438A2 (fr) | Leucolysine/mmp25/mt6-mmp | |
US20050164202A1 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express JPL polypeptides | |
US20040091887A1 (en) | Mucroslysin and its gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20081007 |